A Nifedipine

B Metoproplof

C Methyldopa

D Olmesartan

A Fallopian tubes

B Endometrium

C Ovaries

D Vulvo - vaginal part

A Enhanced by progesterone

B Enhanced by estrogen

C Inhibited by estrogen

D Enhanced by estrogen and Inhibited by progesterone

A There is no increased risk to the baby.

B There may be an increase in cardiovascular malformations

C There may be an increase in nervous system malformations.

D There may be an increase in spontaneous aboions and prematurity.

A Annually

B Every 2 year

C Every 3 year

D Every 5 yaer

A Rubin's test

B HSG

C Laparotomy

D Laparoscopic chromtubation

A Vital capacity is increased

B Subcostal angle remains unchanged

C Tidal volume remains unaltered

D Residual volume Is decreased

A Placenta previa

B Imperforate hymen

C Abruptio placenta

D Abnormal uterine bleeding

A Alfa-fetoprotein

B Human chorionic gonadotropin (hCG)

C Human placental lactogen (HPL

D Unconjugated oestriol

A Stomach and umbilical vein, perpendicular to spine

B Kidneys

C Stomach parallel to spine

D Liver and spleen